newsfilter
← Latest News
GlobeNewswire·

Opiant Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SANTA MONICA, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced, as required by Nasdaq Stock